# MindPeak

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/mindpeak

- Industry: Software
- Headquarters: Hamburg, Germany
- Website: www.mindpeak.ai
- Total disclosed funding: $18M
- Latest round: Series A (Dec 29, 2023)
- Investors on record: 12

## About

MindPeak GmbH innovates in artificial intelligence for clinical pathology, enhancing diagnostic accuracy through its advanced software solutions for tumor identification and biomarker quantification.Founded in 2018 and headquartered in Hamburg, Germany, MindPeak GmbH develops AI solutions for clinical pathology. The company has undergone no significant pivots but has grown its technology offerings since inception. Felix Faber serves as both CEO and Founder, previously leading other ventures. MindPeak has raised a total of USD 15.3 mn in its latest Series A funding round on December 29, 2023, led by ZEISS Ventures and Innovationsstarter Fonds Hamburg, and now holds a valuation of USD 41.13 mn.MindPeak GmbH specializes in developing AI solutions tailored for clinical pathology, focusing on enhancing diagnostic precision and efficiency. The company's core offerings include AI-powered diagnostic software that integrates algorithms into histology-based in vitro diagnostics (IVDs) and companion diagnostics. Key products encompass solutions for quantifying biomarkers such as PD-L1, HER2, and Ki-67 in various cancer types, including breast, gastric, and prostate cancers. These products are designed for seamless integration into the existing workflows of pathologists, enabling automated tumor identification and biomarker quantification without requiring additional user input, termed as "0-click solutions." Mindpeak primarily serves hospitals, clinical laboratories, and research institutions across Europe and North America, enhancing the capabilities of professionals in oncology and pathology.Mindpeak’s revenue model is primarily based on B2B transactions with healthcare providers and laboratories, focusing on subscription-based services and partnerships. The company’s AI solutions are offered through deep integrations with partner software or via its standalone AI console, allowing users to access the technology in a manner that suits their operational needs. Revenue is generated from licensing its proprietary software, which enables pathologists to efficiently evaluate biomarkers and streamline their diagnostic processes. The product suite includes flagship offerings such as the Mindpeak Breast HER2 and Mindpeak Gastric PD-L1, which are designed to facilitate the evaluation of specific cancer biomarkers. Each product meets regulatory standards and is marketed as suitable for research use only, aligning with the company's focus on precision medicine in clinical settings.In December 2023, MindPeak GmbH raised USD 15.3 mn in Series A funding to support the commercialization of its pioneering technologies. The firm aims to expand its market presence across multiple geographical regions. Plans are underway to introduce new products into the market, enhancing its portfolio and capabilities in clinical pathology. The recent capital will facilitate these growth initiatives, allowing MindPeak to enhance its technology and market reach effectively.

## Funding rounds

- Series A, Dec 29, 2023, $15M — Innovationsstarter Fonds Hamburg, Nova Capital, Motu Ventures, Apex Ventures, Nina Capital, European Innovation Council, AI.Fund Management GmbH, non olet, thehighground GmbH, ZEISS Ventures, SVM Verwaltungsgesellschaft mbH
- Seed, Sep 6, 2019, $3M — Nova Capital, Motu Ventures, Apex Ventures, IFB Innovationsstarter GmbH

## Investors

- Nova Capital — Seed, Series A
- Motu Ventures (https://capitalatlas.ai/funds/motu-ventures) — Seed, Series A
- Apex Ventures (https://capitalatlas.ai/funds/apex-ventures) — Seed, Series A
- IFB Innovationsstarter GmbH — Seed
- Innovationsstarter Fonds Hamburg (https://capitalatlas.ai/funds/innovationsstarter-fonds-hamburg) — Series A
- Nina Capital (https://capitalatlas.ai/funds/nina-capital) — Series A
- European Innovation Council (https://capitalatlas.ai/funds/european-innovation-council) — Series A
- AI.Fund Management GmbH — Series A
- non olet — Series A
- thehighground GmbH — Series A
- ZEISS Ventures (https://capitalatlas.ai/funds/zeiss-ventures) — Series A
- SVM Verwaltungsgesellschaft mbH — Series A